FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Sponsors and FDA reviewers will have to adjust to the workload of a drug review shifting earlier in the review cycle as the agency implements Good Review Management Principles, now renamed the "21st Century Review Process."